Search

everythinglearnresearchcommunity

for

Search:↓

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The new FUE device improves hair transplant safety and efficiency.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.

FUE can be successfully done on African-American hair by using larger punch tools and careful techniques to reduce hair damage.

A new compound shows promise as a topical treatment for hair loss.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

PHAT may improve hair growth better than PRP alone.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Clascoterone is safe for the heart, even at high doses.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Apremilast shows promise for several skin conditions but needs more research.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.